DCC - UFMG
+55 31 3409 5860
ciia-saude@dcc.ufmg.br

Francisco de Assis Acurcio


Francisco de Assis Acurcio

Universidade Federal de Minas Gerais
Farmácia Social

Pesquisador colaborador





Informações resumidas do Currículo Lattes


Currículo Lattes atualizado em 30/04/2021

Nome em citações bibliográficas: ACURCIO, F. A.;ACURCIO, F.;ACURCIO, Francisco de Assis;de Assis Acurcio, F.;Acurcio, F. d. A.;Acúrcio, Francisco de Assis;Assis Acurcio, Francisco;Acurcio, Francisco;Acurcio, Francisco A;Acurcio, Francisco A.;ACURCIO, FA;DE ASSIS ACURCIO, FRANCISCO;ACURCIO, FRANCISCO ASSIS;ASSIS ACURCIO, FRANCISCO DE;Francisco de Assis Acurcio;ACURCIO, FRANCISCO DE ASSIS;ACÚRCIO, FRANCISCO A;ACURCIO, FRANSCISO de ASSIS;ACURCIO, F DE A;de Assis Acúrcio F;de Assis Acúrcio F,;DE CURIO, FRANCISCO A.;De Acúrcio FA;ACURCIO FA;ACÚRCIO, FRANCISCO ASSIS;ACURCIO, F. A;ACÚRCIO, FRANCISCO;DE ASSIS ACÚRCIO, FRANCISCO


Formação acadêmica

Doutorado em Ciência Animal na Universidade Federal de Minas Gerais em 1998
Mestrado em Economía de La Salud y del Medicamento na Universitat Pompeu Fabra em 2005
Mestrado em Saúde Pública na Universidade Federal de Minas Gerais em 1995
Graduado em Medicina na Universidade Federal de Minas Gerais em 1981


Projetos de pesquisa em andamento

2015 a AtualComparative clinical effectiveness of high cost medicines
This project aims to: 1) Implement deterministic-probabilistic record linkage from the databases of the Brazilian National Health System (SUS) for the use of statins to treat high levels of cholesterol in blood; 2) Evaluate the effectiveness and safety of medicines utilized for the treatment of patients with rheumatic disease (rheumatoid arthritis (RA), psoriatic arthritis (PA) and ankylosing spondylitis (AS)) using a standardized questionnaire. The proposal is to expand the number of interviews that are performed actually (three times at intervals of at least six months) to six times in the same range. The study allows information such as demographics, medication use and adverse reactions, comorbidities, measures of disease activity, functional capacity and quality of life; and, 3) Evaluate the comparative clinical effectiveness of insulin glargine analogue for the treatment of patients with Diabetes Mellitus type 1: systematic review of observational studies comparing insulin glargine analog with other insulins and cohort of patients using insulin glargine analog in in patients who started treatment with insulin glargine analog in January to December 2011. To analyze the clinical effectiveness of the insulin analogue glargine the patient is compared in an baseline analysis and after. It will be checked if there was control of blood glucose levels (glycated hemoglobin) and there are reports of reduced hypoglycemia crisis.
Integrantes: AUGUSTO AFONSO GUERRA JUNIOR (coordenador), Francisco de Assis Acurcio, Juliana Álvares, Daniel Resende Faleiros, Alessandra Maciel Almeida, Renata Cristina Resende Macedo, Brian Godman, Marion Bennie, Samantha Alvarez-Madrazo.
2014 a AtualAvaliação da efetividade da terapia antirretroviral nas coinfecções HIV/tuberculose, HIV/hanseníase e HIV/leishmaniose visceral em Belo Horizonte- Projeto ECOART
As coinfecções aumentam a morbidade e mortalidade das pessoas que vivem com HIV/aids (PVHA), como por exemplo: tuberculose (TB), leishmaniose visceral (LV), hanseníase, hepatite C, sífilis entre outras. A TB é a maior causa de morte entre PVHA, sendo a taxa de óbito na coinfecção de 20%. As coinfecções HIV/hanseníase e HIV/LV têm sido pouco estudadas no Brasil e no mundo, apesar de serem consideradas problemas de saúde pública. Esse estudo será analítico do tipo coorte concorrente, a ser realizado no Hospital Eduardo de Menezes (HEM) da Fundação Hospitalar do Estado de Minas Gerais (FHEMIG) em Belo Horizonte. O objetivo desse projeto é avaliar a efetividade da terapia antirretroviral em pessoas vivendo com HIV/tuberculose, HIV/hanseníase ou HIV/leishmaniose visceral. Espera-se com este estudo, identificar os fatores associados com a efetividade da terapia antirretroviral, no intuito de propor intervenções para aumentar adesão, reduzir o abandono e promover a cura das coinfecções
Integrantes: Maria das Graças Braga Ceccato (coordenador), Francisco de Assis Acurcio, Mark Drew Crosland Guimarães, Palmira de Fátima Bonolo, Wânia da Silva Carvalho, Dirce Inês da Silva, Micheline Rosa Silveira, Juliana de Oliveira Costa, Celline Cardoso Almeida, Silvana Espíndola de Miranda, Natália Helena Resende, Daniela Mendes, Angélica Bueno, Regiane Paiva, Laura Torres.
2013 a AtualEfetividade do tratamento com agentes biológicos em pacientes com artrite reumatoide, espondilite anquilosante e artrite psoriásica no Sistema Único de Saúde em Minas Gerais: uma coorte prospectiva.
Coorte prospectiva de pacientes portadores de Artrite Reumatica, Artrite Psoriatica e Espondilite Anquilosante em tratamento com os agentes biológicos infliximabe, etanercepte, adalimumabe e rituximabe na Gerência Regional de Saúde (GRS) de Belo Horizonte, Minas Gerais. Essa investigação dá sequencia e integra o Projeto ?Avaliação da efetividade e segurança dos anticorpos monoclonais adalimumabe, etanercepte, infliximabe e rituximabe utilizados no tratamento da artrite reumatóide, artrite psoriásica e espondilite anquilosante, Brasil e Minas Gerais?
Integrantes: Francisco de Assis Acurcio (coordenador), Augusto Afonso Guerra Junior, Juliana Álvares, Cristiano Soares Moura, Grazielle Dias da Silva, Marina Amaral de Ávila Machado, Alessandra Maciel Almeida, Renata Cristina Resende Macedo, Andrade, Eli Iôla Gurgel, Juliana de Oliveira Costa, Adriana Maria Kakehasi, Cherchiglia, Mariangela Leal, Haliton de Oliveira, Clarice Gomes e Souza Dabes, Jessica Barreto dos Santos.
2013 a AtualPesquisa nacional de acesso, utilização e uso racional de medicamentos (PNAUM) - componente serviços
A PNAUM (Pesquisa nacional de acesso, utilização e uso racional de medicamentos) - componente serviços tem por objetivos: 1. Caracterizar a organização dos serviços de assistência Farmacêutica na Atenção Básica do Sistema Único Saúde, tendo em vista o acesso e a promoção do uso racional de medicamentos. 2. Identificar e discutir fatores que interferem na consolidação da Assistência Farmacêutica na Atenção Básica no âmbito municipal/DF. A pesquisa será realizada em 600 municípios brasileiros. Serão entrevistados secretários municipais de saúde e responsáveis pela assistência farmacêutica em cada um dos municípios. Posteriormente, dos 600 municípios serão sorteados 300, onde serão entrevistados usuários, médicos e dispensadores de medicamentos. Além disso serão observadas as instalações físicas e caracterizada a estrutura da rede pública para a assistência farmacêutica. A partir da PNAUM serão possíveis análises relacionadas às diferentes dimensões de acesso, o estudo de indicadores de racionalidade do uso e grau de seguimento das prescrições em relação à adesão e aos cuidados com doenças de alta prevalência como hipertensão arterial e diabetes. Será ainda possível conhecer a infra-estrutura dos serviços farmacêuticos no país, o local de obtenção dos medicamentos (farmácia pública, unidade básica de saúde, entre outros), a estrutura física e o processo de trabalho nos almoxarifados e nas unidades dispensadoras. Serão também identificados os perfis dos profissionais que trabalham na assistência farmacêutica, os principais desafios dos gestores e a aceitabilidade dos usuários. Adicionalmente, a pesquisa possibilitará a realização de um estudo de utilização de medicamentos, caracterizando as morbidades ou condições de saúde em relação à classe terapêutica, número de medicamentos utilizados, motivos do uso, disponibilidade de medicamentos na atenção primária à saúde, existência de relações de medicamentos adequadas às realidades locais e o conhecimento destas listas pelos profissionais de saúde. Por fim, será caracterizado o uso e o acesso a medicamentos segundo variáveis sócio demográficas, econômicas, clinicas, de estilo de vida e organização do serviço
Integrantes: Juliana Álvares (coordenador), Francisco de Assis Acurcio, Ediná Alves Costa, Daniel Resende Faleiros, Alessandra Maciel Almeida, Micheline Rosa Silveira, Vânia Eloísa de Araújo, Renata Cristina Resende Macedo Nascimento, Clarice Chemello, AUGUSTO AFONSO GUERRA JUNIOR, Karen Sarmento Costa, Silvana Nair Leite, Orlando Mário Soeiro, Margô Gomes de Oliveira Karnikowski, Ione Aquemi Guibu.
2011 a AtualAvaliação epidemiológica e econômica dos esquemas terapêuticos utilizados no tratamento do Diabetes Mellitus em Minas Gerais
O estudo busca conhecer o perfil de tratamento e de gastos com medicamentos utilizados por indivíduos portadores de diabetes mellitus em Minas Gerais, para produzir informações que viabilizem a elaboração e implantação de um programa de acompanhamento farmacoterapêutico nas farmácias comunitárias públicas do SUS/MG. Para isto, tem como objetivos específicos: I. Construir base de dados relativa aos indivíduos em tratamento de Diabetes Mellitus no Estado de Minas Gerais; II. Avaliar quantitativamente o perfil de utilização de medicamentos por portadores de diabetes em Minas Gerais; III. Avaliar qualitativamente os serviços de assistência farmacêutica realizados pelos farmacêuticos responsáveis pela farmácia pública de Minas Gerais; IV. Realizar revisão sistemática enfocando estimativas de probabilidades inerentes à história natural da doença e aquelas relacionadas às alternativas terapêuticas do tratamento para Diabetes Mellitus oferecido no SUS/MG (eficácia, efetividade e segurança); V. Avaliar os gastos realizados com o tratamento do Diabetes Mellitus oferecido nas farmácias públicas do SUS em Minas Gerais; VI. Realizar análise de custo-efetividade dos esquemas terapêuticos empregados no tratamento do Diabetes Mellitus no SUS/MG; VII. Capacitar os farmacêuticos do SUS/MG para a realização de acompanhamento farmacoterapêutico; VIII. Desenvolver e aplicar uma metodologia de acompanhamento farmacoterapêutico para indivíduos portadores de Diabetes Mellitus; IX. Contribuir para o estreitamento das relações entre profissionais farmacêuticos, pacientes e prescritores.
Integrantes: Francisco de Assis Acurcio (coordenador), Mariângela Leal Cherchiglia, Augusto Afonso Guerra Junior, Juliana Álvares, Eli Iola Gurgel Andrade, Daniel Resende Faleiros, Grazielle Dias da Silva, Renata Cristina Resende Macedo, Yara Alvarenga Drumond, Leonardo Maurício Diniz, Ana Luísa Caires de Souza, Felipe Ferre, Liziane Silva, Vânia Eloísa de Araújo, Clarice Chemello.
2010 a AtualAvaliação da efetividade e segurança de anticorpos monoclonais adalimumabe, etanercepte, infliximabe e rituximabe utilizados no tratamento da artrite reumatóide, artrite psoriática e espondilite anquilosante, Brasil e Minas Gerais
As condições reumatológicas, artrite reumatóide (AR) artrite psoriática (AP) e espondilite anquilosante (EA), são doenças inflamatórias crônicas que acometem parte da população nacional. O tratamento destas condições pode ser de origem sintomática (corticosteróides e anti-inflamatórios não-esteroidais) ou atuar diretamente no processo da doença (os chamados medicamentos anti-reumáticos modificadores da resposta biológica). Uma nova abordagem, com agentes anti-TNF, vem sendo utilizada como opção de tratamento no SUS para os pacientes acometidos de doenças reumáticas. O objetivo deste projeto é avaliar a segurança e a efetividade dos agentes anti-TNF - adalimumabe, etanercepte, infliximabe e rituximabe - em pacientes com AR, AP e EA, por meio de revisão sistemática de literatura e de estudos de coorte, retrospectiva para avaliação da segurança em nível nacional e prospectiva para avaliação da efetividade nas 4 maiores Gerências Regionais de Saúde (GRS) do Estado de Minas Gerais. O projeto tem como resultados esperados o aprimoramento da farmacoterapêutica das condições reumáticas em estudo, o desenvolvimento de uma estratégia para estudo de segurança de medicamentos a partir de bases de dados administrativas e a consolidação do conhecimento sobre os medicamentos anti-TNF.
Integrantes: Francisco de Assis Acurcio (coordenador), Mariângela Leal Cherchiglia, Maria das Graças Braga Ceccato, Augusto Afonso Guerra Junior, Cristiano Soares Moura, Eli Iola Gurgel Andrade, Daniel Resende Faleiros, Grazielle Dias da Silva, Marina Amaral de Ávila Machado, Renata Cristina Resende Macedo, Yara Alvarenga Drumond, Ana Luísa Caires de Souza, Felipe Ferre, Liziane Silva, Marli Jerônimo de Paulo, Adriana Maria Kakehasi.
2000 a AtualSaúde Coletiva e Assistência Farmacêutica
Estuda a saúde das coletividades humanas em suas dimensões biológica e social. Analisa os aspectos epidemiológicos, culturais, políticos e organizacionais pertinentes à saúde humana. Enfoca a assistência farmacêutica, o medicamento e sua utilização. Tem como objetivo geral contribuir na produção de conhecimentos que subsidiem a implementação de um modelo de Assistência Farmacêutica no SUS que considere como atividades inerentes à sua organização: a pesquisa, a produção, a distribuição, o armazenamento, a prescrição, a dispensação, entendida esta como ato essencialmente de orientação quanto ao uso adequado e a farmacovigilância do medicamento.
Integrantes: Francisco de Assis Acurcio (coordenador), Edson Perini, Gil Sevalho, Cibele Comini Cesar, Sérgia Maria Starling Magalhães, Djenane Ramalho de Oliveira, Augusto Afonso Guerra Junior, Yone de Almeida Nascimento, Wânia da Silva Carvalho, Erika Lourenço de Freitas.

Projetos de desenvolvimento em andamento

Veja todos os projetos no Currículo Lattes

Últimas publicações

Artigos em periódicos

A cross-sectional study of the quality of life of patients living with type 1 diabetes treated with insulin glargine and neutral protamine Hagedorn insulin and the implications
2021. Journal of Pharmaceutical Health Services Research.
Influence of pharmaceutical services organization on the availability of essential medicines in a public health system
2021. Journal of Comparative Effectiveness Research.
Dezesseis Anos de Transplante Cardíaco em Coorte Aberta no Brasil: Análise de Sobrevivência de Pacientes em Uso de Imunossupressores
2021. Arquivos Brasileiros de Cardiologia.
Effectiveness and safety of anti-TNF therapy for ankylosing spondylitis: a real-word study
2021. Journal of Comparative Effectiveness Research.
Strategies to improve the availability of medicines in primary health care in Brazil: findings and implications
2021. Journal of Comparative Effectiveness Research.
The Budget Impact of Monoclonal Antibodies Used to Treat Metastatic Colorectal Cancer in Minas Gerais, Brazil
2021. Applied Health Economics and Health Policy.
Economic evaluation of adalimumab versus etanercept for psoriatic arthritis in a Brazilian real-world model
2021. Expert Review of Pharmacoeconomics & Outcomes Research.
Cost-utility analysis of the anti-TNF therapy for rheumatoid arthritis in a real-world based model
2020. Expert Review of Pharmacoeconomics & Outcomes Research.
Sixteen-Year Cohort of Liver Transplantation in the National Health System in Brazil: Analysis of Immunosuppression Maintenance Therapies
2020. Frontiers in Pharmacology.
Effectiveness of Maintenance Immunosuppression Therapies in a Matched-Pair Analysis Cohort of 16 Years of Renal Transplant in the Brazilian National Health System
2020. International Journal of Environmental Research and Public Health.
Real-world evaluation of the impact of statin intensity on adherence and persistence to therapy: A Scottish population-based study
2020. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY.
Uso de medicamentos por adultos na atenção primária: inquérito em serviços de saúde de Minas Gerais, Brasil
2020. REVISTA BRASILEIRA DE EPIDEMIOLOGIA.
Immune checkpoint inhibitors? (ICI) efficacy according to PD-L1 expression for advanced or metastatic NSCLC: Systematic review and meta-analysis.
2020. JOURNAL OF CLINICAL ONCOLOGY.
Academic detailing program for rheumatoid arthritis: a contribution to Brazilian public health system sustainability
2020. JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH.
Polypharmacy, socioeconomic indicators and number of diseases: results from ELSA-Brasil
2020. REVISTA BRASILEIRA DE EPIDEMIOLOGIA.
Effectiveness of first-line treatment for relapsing-remitting multiple sclerosis in Brazil: A 16-year non-concurrent cohort study
2020. PLoS One.
Risk factors associated with antineoplastic chemotherapy-induced nausea and vomiting
2020. REVISTA DE SAUDE PUBLICA.
Polypharmacy among adult and older adult users of primary care services delivered through the Unified Health System in Minas Gerais, Brazil
2020. Expert Review of Clinical Pharmacology.
Integrative Review of Managed Entry Agreements: Chances and Limitations
2020. PHARMACOECONOMICS.
Impact of biologic DMARDs on quality of life: 12-month results of a rheumatic diseases cohort using the Brazilian EQ-5D tariff
2020. HOSPITAL PRACTICE.
Comparative persistence of anti-tumor necrosis factor therapy in ankylosing spondylitis patients: a multicenter international study
2020. CURRENT MEDICAL RESEARCH AND OPINION.
First line of subcutaneous anti-TNF therapy for rheumatoid arthritis: a prospective cohort study
2020. Expert Review of Clinical Immunology.
Cost Analysis of Cancer in Brazil: A Population-Based Study of Patients Treated by Public Health System, From 2001-2015
2020. VALUE IN HEALTH REGIONAL ISSUES (PRINT).
Real world effectiveness of olanzapine and risperidone in the treatment of schizophrenia in Brazil over a 16-year follow-up period; findings and implications
2020. Expert Review of Clinical Pharmacology.
PP406 Academic Detailing For Judges: Concepts Of Evidence-Based Medicine And Health Policies Adopted In Brazil
2020. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE.
Medication persistence for psoriatic arthritis in a Brazilian real-world setting
2019. Future Science OA.
First line of biological drugs in rheumatoid arthritis: a medication persistence analysis
2019. Expert Review of Clinical Pharmacology.
Who should pay for the continuity of post-trial health care treatments?
2019. International Journal for Equity in Health.
Cost-related underuse of medications in older adults
2019. REVISTA DE SAÚDE PÚBLICA (ONLINE).
Health-related quality of life among HIV-infected patients initiating treatment in Brazil in the single-tablet regimen era
2019. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV.
Confidentiality agreements: a challenge in market regulation
2019. International Journal for Equity in Health.
Relationship Between Length of Exposure to Trauma and Mental Illness in the Police
2019. Journal of Neurology and Psychology.
Indicator of access to medicines in relation to the multiple dimensions of access
2019. Journal of Comparative Effectiveness Research.
(Un)Equitable distribution of health resources and the judicialization of healthcare: 10 years of experience in Brazil
2019. International Journal for Equity in Health.
Biological therapy in the treatment of psoriatic arthritis: economic and epidemiological considerations
2019. Expert Review of Clinical Immunology.
Discontinuation, persistence and adherence to subcutaneous biologics delivered via a homecare route to Scottish adults with rheumatic diseases: a retrospective study
2019. BMJ Open.
Access to high-cost medications for psoriatic arthritis in the National Health System in Brazil: the long path up to dispensation
2019. Advances in Rheumatology.
Effectiveness and safety of insulin glargine versus detemir analysis in patients with type 1 diabetes: systematic review and meta-analysis
2018. Therapeutic Advances in Endocrinology and Metabolism.
Quality of Life of Patients with Type 1 Diabetes Mellitus Using Insulin Analog Glargine Compared with NPH Insulin: A Systematic Review and Policy Implications
2018. Patient-Patient Centered Outcomes Research.
Statin use in Brazil: findings and implications
2018. CURRENT MEDICAL RESEARCH AND OPINION.
Monitoring self-reported adherence to antiretroviral therapy in public HIV care facilities in Brazil
2018. MEDICINE.
Perfil de gastos com o tratamento da Artrite Reumatoide para pacientes do Sistema Único de Saúde em Minas Gerais, Brasil, de 2008 a 2013
2018. Ciência & Saúde Coletiva.
Hipoglicemiantes Orais Para Diabetes Mellitus Tipo 2: Comparação de Preços no Brasil e em Outros Sistemas Universais de Saúde
2018. VALUE IN HEALTH REGIONAL ISSUES (PRINT).
The long-term costs for treating multiple sclerosis in a 16-year retrospective cohort study in Brazil
2018. PLoS One.
Crohn?s Disease Treatment Expenditures over Fifteen Years of Follow-Up
2018. Pharmacoeconomics open access.
Costs in the Treatment of Schizophrenia in Adults Receiving Atypical Antipsychotics: An 11-Year Cohort in Brazil
2018. Applied Health Economics and Health Policy.
Uso de medicamentos e fatores associados à polifarmácia em indivíduos com diabetes mellitus em Minas Gerais, Brasil
2018. Ciência & Saúde Coletiva.
Effectiveness and safety of anti-TNF in psoriatic arthritis patients in Brazil: a post-incorporation analysis
2018. Journal of Comparative Effectiveness Research.
Building the National Database of Health Centred on the Individual: Administrative and Epidemiological Record Linkage - Brazil, 2000-2015
2018. International Journal of Population Data Science.
Effectiveness of antiretroviral therapy in the single-tablet regimen era
2018. REVISTA DE SAÚDE PÚBLICA (ONLINE).
Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination with Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
2018. BIODRUGS.
Access to medicines: relations with the institutionalization of pharmaceutical services
2017. REVISTA DE SAÚDE PÚBLICA (ONLINE).
Conceptions on pharmaceutical services in Brazilian primary health care
2017. REVISTA DE SAÚDE PÚBLICA (ONLINE).
The clinical effectiveness of insulin glargine in patients with Type I diabetes in Brazil: findings and implications
2017. Journal of Comparative Effectiveness Research.
National Survey on Access, Use and Promotion of Rational Use of Medicines: methods
2017. REVISTA DE SAÚDE PÚBLICA (ONLINE).
Characterization of the institutionalization of pharmaceutical services in Brazilian primary health care
2017. REVISTA DE SAÚDE PÚBLICA (ONLINE).
Pharmaceutical services in the primary health care of the Brazilian Unified Health System: advances and challenges
2017. REVISTA DE SAÚDE PÚBLICA (ONLINE).
Pharmaceutical services in primary health care: interfederative agreement in the development of pharmaceutical policies in the Brazilian Unified Health System (SUS)
2017. REVISTA DE SAÚDE PÚBLICA (ONLINE).
A Critical Look at Innovation Profile and Its Relationship with Pharmaceutical Industry
2017. International Journal of Scientific Research and Management.
Pharmaceutical care in Brazil?s primary health care
2017. REVISTA DE SAÚDE PÚBLICA (ONLINE).
Avaliação da infraestrutura da Assistência Farmacêutica no Sistema Único de Saúde em Minas Gerais
2017. Ciencia & Saude Coletiva.
HEALTH TECHNOLOGY PERFORMANCE ASSESSMENT: REAL-WORLD EVIDENCE FOR PUBLIC HEALTHCARE SUSTAINABILITY
2017. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE.
Gender differences and psychotropic polypharmacy in psychiatric patients in Brazil: a cross-sectional analysis of the PESSOAS Project
2017. Cadernos de Saude Publica.
Patient survival and risk of death after prostate cancer treatment in the Brazilian Unified Health System
2017. REVISTA DE SAUDE PUBLICA.
Cost-effectiveness of vildagliptin for people with Type 2 Diabetes Mellitus in Brazil; findings and implications
2017. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH.
Consumer Willingness to Pay for Dengue Vaccine (CYD-TDV, Dengvaxia®) in Brazil; Implications for Future Pricing Considerations
2017. Frontiers in Pharmacology.
Avaliação econômica dos Programas Rede Farmácia de Minas do SUS versus Farmácia Popular do Brasil
2017. Ciência & Saúde Coletiva (Online).
Availability of essential medicines in primary health care of the Brazilian Unified Health System
2017. REVISTA DE SAÚDE PÚBLICA (ONLINE).
Characterization of the selection of medicines for the Brazilian primary health care
2017. REVISTA DE SAÚDE PÚBLICA (ONLINE).
Health-related quality of life of patients of Brazilian primary health care
2017. REVISTA DE SAÚDE PÚBLICA (ONLINE).
Medicine dispensing service in primary health care of SUS
2017. REVISTA DE SAÚDE PÚBLICA (ONLINE).
Polypharmacy: a challenge for the primary health care of the Brazilian Unified Health System
2017. REVISTA DE SAÚDE PÚBLICA (ONLINE).
Perfil dos usuários com doenças reumáticas e fatores associados à qualidade de vida no sistema único de saúde, Brasil
2017. Revista Médica de Minas Gerais.
The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil
2017. PHARMACOECONOMICS.
Improving community mobilization in HIV treatment management: practical suggestions from patients in Brazil
2017. REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH.
Indicators related to the rational use of medicines and its associated factors
2017. REVISTA DE SAÚDE PÚBLICA (ONLINE).
Patient satisfaction with pharmaceutical services in Brazilian primary health care
2017. REVISTA DE SAÚDE PÚBLICA (ONLINE).
Access to medicines by patients of the primary health care in the Brazilian Unified Health System
2017. REVISTA DE SAÚDE PÚBLICA (ONLINE).
Technical issues and conservation conditions of medicines in the primary health care of the Brazilian Unified Health System
2017. REVISTA DE SAÚDE PÚBLICA (ONLINE).
Use of medicines by patients of the primary health care of the Brazilian Unified Health System
2017. REVISTA DE SAÚDE PÚBLICA (ONLINE).
Main characteristics of patients of primary health care services in Brazil
2017. REVISTA DE SAÚDE PÚBLICA (ONLINE).
Workforce in the pharmaceutical services of the primary health care of SUS, Brazil
2017. REVISTA DE SAÚDE PÚBLICA (ONLINE).
Management of pharmaceutical services in the Brazilian primary health care
2017. REVISTA DE SAÚDE PÚBLICA (ONLINE).
Financing of Pharmaceutical Services in the municipal management of the Brazilian Unified Health System
2017. REVISTA DE SAÚDE PÚBLICA (ONLINE).
Infrastructure of pharmacies of the primary health care in the Brazilian Unified Health System: Analysis of PNAUM - Services data
2017. REVISTA DE SAÚDE PÚBLICA (ONLINE).
Health self-assessment by hemodialysis patients in the Brazilian Unified Health System
2016. Revista de Saúde Pública (Online).
Estamos de fato medindo acesso? Revisão sistemática das medidas de acesso a medicamentos no Brasil
2016. REVISTA BRASILEIRA DE PESQUISA EM SAÚDE.
Quality of life of patients with Diabetes Mellitus Types 1 and 2 from a referal health centre in Minas Gerais, Brazil
2016. Expert Review of Clinical Pharmacology.
Clinical Effectiveness and Safety of Analog Glargine in Type 1 Diabetes: A Systematic Review and Meta-Analysis
2016. Diabetes Therapy.
Ten-year kidney transplant survival of cyclosporine- or tacrolimus-treated patients in Brazil
2016. Expert Review of Clinical Pharmacology.
Implementation of clinical guidelines in Brazil: should academic detailing be used?
2016. Journal of Pharmaceutical Health Services Research.
Budget impact analysis of medicines: updated systematic review and implications
2016. EXPERT REV PHARM OUT.
Real Life Experience of First Course of Anti-TNF Treatment in Ankylosing Spondylitis Patients in Brazil
2016. Rheumatology and Therapy.
Efficacy, safety and effectiveness of ondansetron compared to other serotonin-3 receptor antagonists (5-HT 3 RAs) used to control chemotherapy-induced nausea and vomiting: systematic review and meta-analysis
2016. Expert Review of Clinical Pharmacology.
Acesso aos medicamentos para tratamento da doença de Alzheimer fornecidos pelo Sistema Único de Saúde em Minas Gerais, Brasil
2016. Cadernos de Saúde Pública (Online).
Costs of Drug Therapy in Patients with Ankylosing Spondylitis in Brazil
2016. Rheumatology and Therapy.
Incidência de hepatite viral C em pacientes em hemodiálise no Brasil entre 2000 e 2003
2016. Cadernos de Saúde Pública (Online).
Treatment persistence in patients with rheumatoid arthritis and ankylosing spondylitis
2016. Revista de Saúde Pública (Online).
Comparative effectiveness of adalimumab and etanercept for rheumatoid arthritis in the Brazilian Public Health System
2016. Journal of Comparative Effectiveness Research.
Evaluation of primary health care by users and non-users of drugs hospitalized for primary care-sensitive conditions
2016. Atención Primaria (Barcelona. Ed. impresa).
Medication persistence of DMARDs and anti-TNF agents in a cohort of patients with rheumatoid arthritis in Brazil
2016. Arthritis Care & Research (Print).
Análisis coste-efectividad de la adhesión inicial a la terapia antirretroviral entre individuos infectados por el VIH en Belo Horizonte, Brasil
2006. Revista Española de Salud Pública.
Non-adherence among patients initiating antiretroviral therapy: a challenge for health professionals in Brazil
2005. AIDS (London).
Health care utilization and survival among patients with Aids in Belo Horizonte, Minas Gerais, Brazil
1998. Cadernos de Saúde Pública (FIOCRUZ).

Trabalhos completos em congressos

Formulations of amphotericin B for the treatment of fungal infections in patients with HIV/AIDS
2013. ISPOR 4th Latin America Conference. 0
Modelos de assistência farmacêutica no Brasil: Programa Rede Farmácia de Minas e Programa Farmácia Popular do Brasil
2012. Convención Internacional de Salud Pública. Cuba Salud 2012. 1
Interações medicamentosas entre pacientes idosos em um hospital de médio porte do interior da Bahia
2008. XVIII IEA World Congress of Epidemiology & VII Congresso Brasileiro de Epidemiologia. 2
Complexidade das prescrições de medicamentos entre indivíduos infectados pelo HIV e auto-relato de adesão à terapia anti-retroviral
2006. XV Semana de Iniciação Científica UFMG. 3
Comparativo da evolução do gasto público com medicamentos no Ceará a partir dos dados do SIOPS
2006. III Jornada de Economia da Saúde. 4

Resumos expandidos em congressos

Eficiência da intercambialidade de medicamentos de referência por genéricos utilizados por idosos em Belo Horizonte, Brasil
2006. II Congreso de Economia de la Salud de America Latina y el Caribe.
Aspectos económicos y efectividad de la adhesión al tratamiento anti-retroviral en individuos infectados por el VIH en Belo Horizonte, Brasil
2005. XXV Jornadas de Economía de la Salud: Economía de la Salud Dónde estamos 25 años después? Aspectos económicos y efectividad de la adhesión al tratamiento anti-retroviral en individuos infectados por el VIH en Belo Horizonte, Brasil.

Resumos em congressos

4877. Safety of disease modifying drugs in pregnant women with relapsing-remitting multiple sclerosis: Systematic review and meta-analysis
2020. ICPE All Access Conference.
4863. Eculizumab in pregnant women: A viable alternative toprevent invasive hemolysis?
2020. ICPE All Access Conference.
3732. Antidepressant use among adults patients in primary care in Brazil: Results of a national survey
2020. ICPE All Access Conference.
4915 Infectious processes and schizophrenia: Is there any correlation?
2020. ICPE All Access Conference.
982 Effectiveness and safety of eculizumab in the treatment of paroxysmal nocturnal hemoglobinuria: Systematic review and metaanalysis
2019. 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
1119 Polypharmacy and associated factors in primary healthcare users of the unified health system in Minas Gerais state, Brazil
2019. 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
996 Medication persistence in the first line of biological drugs in rheumatoid arthritis
2019. 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
946 Impact of intensity of statin therapy on patients' persistence to treatment: a Scottish population‐based study
2019. 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
87 Does Single‐Tablet Regimen Improve Adherence to Antiretroviral Therapy in Brazil? A Group‐Based Trajectory Modeling Analysis of Patients Switching Regimens
2019. 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
86 Investigating the Impact of Statin Intensity on Patients' Discontinuation of StatinTherapy: A Nationwide Cohort Study
2019. 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Effectiveness Of Insulin Glargine Versus Detemir In Type 1 Diabetes
2018. HTAi 2018 Annual Meeting.
Providing Information About Rheumatoid Arthritis Guideline In Brazil
2018. HTAi 2018 Annual Meeting.
PHP103 Analysis of Minimization of Costs of Equivalent Therapeutic Alternatives (ATE) in a General Hospital of Belo Horizonte / Mg, Brazil
2018. ISPOR 23rd International Meeting.
Analysis of health policy to improve access to medicines in Brazil
2018. HTAi 2018 Annual Meeting.
Associated factors renal graft loss using real-world evidence in Brazil
2018. HTAi 2018 Annual Meeting.
Is Insulin Therapy Important for the Quality of Life of Diabetics?
2018. HTAi 2018 Annual Meeting.
Cardiac Safety Of Trastuzumab For Metastatatic Breast Cancer
2018. HTAi 2018 Annual Meeting.
Risk of diabetes mellitus amongrheumatoid arthritis patients taking TNFinhibitors with or without non‐biologicDMARDs and corticosteroid: A population‐based cohort study [578]
2018. 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
PHS110 One Decade Cost of Cancer Treatment in Brazil and Its Determinants
2018. ISPOR 23rd International Meeting.
Supply of drugs for the treatment of psoriatic arthritis in the Brazilian public health system [925]
2018. 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Risk of diabetes mellitus among rheumatoid arthritis patients taking non‐biologic DMARDS: A population‐based study [577]
2018. 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Efficacy of enzyme replacementtherapy for Hunter syndrome [478]
2018. 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Safety of enzyme replacement therapy for mucopolysaccharidosis II [479]
2018. 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
181. Use of Statins in Primary Health Care ? Brazil
2017. 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
VP49 - Brazilian Consumer Willingness To Pay For Dengue Vaccine (CYD-TDV)
2017. XIV HTAi Annual Meeting.
VP187 - Budgetary Impact Analysis: Real-World Evidence Vs Theoretical Results
2017. XIV HTAi Annual Meeting.
VP176 - Effectiveness Of Anti-TNF In Patients With Psoriatic Arthritis
2017. XIV HTAi Annual Meeting.
OP129 - Predictors Of Effectiveness In Patients With Rheumatoid Arthritis
2017. XIV HTAi Annual Meeting.
250. Quality of Life of People Living with HIV/ AIDS Initiating Antiretroviral Therapy in the Single Tablet Regimen Era
2017. 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
VP53 - Cost-Utility Analysis : Adalimumab Verus Etanercept in RA ? Brazil
2017. XIV HTAi Annual Meeting.
Avaliação de desempenho da assistência farmacêutica no Sistema Único de Saúde em Minas Gerais
2017. 3º Congresso Brasileiro de Política, Planejamento e Gestão em Saúde.
PMH52 Efficacy, safety and cost-effectiveness of aripiprazole compared to olanzapine for schizophrenia: systematic review and meta-analysis
2017. ISPOR 22nd Annual International Meeting.
Safety of Bevacizumab versus no-Bevacizumab treatment used on metastatic colorectal cancer: a systematic review and meta-analysis
2017. The European Cancer Congress.
568. A Comparison of Single versus MultipleTablet Regimens in HIV-Infected People Initiating Antiretroviral Therapy
2017. 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
206. NPH Insulin Use by Patients with Type 2 Diabetes Mellitus in Minas Gerais, Brazil: Prevalence and Associated Factors
2017. 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Efetividade de antirretrovirais na era de medicamentos em dose fixa combinada e fatores associados
2017. XX Congresso Brasileiro de Infectologia.
902. Linkage to Care of Patients Living with HIV/ AIDS in a Reference Hospital of Minas Gerais, Brazil
2017. 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
7.3 Sociodemographic characteristics of type 1 diabetes? patients using insulin glargine in a state in Brazil: are there barriers in access?
2017. European Drug Utilisation Research Group Conference.
13.4 Comparing utilisation of subcutaneous biologics delivered through homecare services in a cohort of patients with rheumatic diseases
2017. European Drug Utilisation Research Group Conference.
12.9 Statins use in primary care of the Unified Health System (SUS) - Brazil
2017. European Drug Utilisation Research Group Conference.
9.6 A real world evaluation of the clinical effectiveness, safety and direct medical expenditure of high intensity statin therapy in high risk patients: A study protocol
2017. European Drug Utilisation Research Group Conference.
12.2 Persistence of statins therapy in Brazil and Scotlan
2017. European Drug Utilisation Research Group Conference.
7.2 Quality of life of patients in type 1 diabetes in use of insulin glargine versus NPH: systematic review
2017. European Drug Utilisation Research Group Conference.
3.9 Cost-effectiveness of therapy with trastuzumab for metastatic breast cancer: how much are we paying for more for the benefit of a new technology?
2017. European Drug Utilisation Research Group Conference.
3.8 Trastuzumab for metastatic breast cancer: systematic review and metaanalysis
2017. European Drug Utilisation Research Group Conference.
14.1 First case of disinvestment using real-world evidence in Brazil; implications for the future
2017. European Drug Utilisation Research Group Conference.
PMH37- Costs with high cost drugs for patients with schizophrenia attended by Brazilian public health system in eleven years follow-up
2016. ISPOR 21st Annual International Meeting.
74 A Health technology performance assessment: Real- world evidence guiding disinvestment
2016. HTAi 2016 Annual Meeting.
28 B Anti-tnf α drugs for the treatment of rheumatoid arthritis in the public health system, Brazil: a prospective cohort
2016. HTAi 2016 Annual Meeting.
127 B Efficacy and safety of betainterferons-1a 3 µg for Multiple Sclerosis: a systematic review
2016. HTAi 2016 Annual Meeting.
135 B ?Pink pill?: Does it add to non-pharmacological treatment of hypoactive sexual desire disorder?
2016. HTAi 2016 Annual Meeting.
117 A Costs with medicines and services in treatment of patients with schizophrenia
2016. HTAi 2016 Annual Meeting.
OS 241 Efficacy, safety and cost-effectiveness of aripiprazole for schizophrenia: a systematic review
2016. HTAi 2016 Annual Meeting.
PSY88 - Efficacy and safety of rituximab for systemic lupus treatment: Systematic review
2016. ISPOR 21st Annual International Meeting.
PIN6 - Efficacy, safety, and cost-effectiveness of 13-valent pneumococcal vaccine: Overview of the literature for incorporation purposes
2016. ISPOR 21st Annual International Meeting.
Polypharmacy: Prevalence and Associated Factors in Elderly with Diabetes Mellitus in Minas Gerais, Brazil [616]
2016. 32nd ICPE.
PUK6 - Associated factors with graft loss in kidney transplantation patients who used maintenance immunosuppressive regimens containing cyclosporine or tacrolimus in SUS
2016. ISPOR 21st Annual International Meeting.
Quality of life outcomes of a 12-month-follow-up Brazilian cohort of patients with rheumatic diseases using biological agents [890]
2016. 32nd ICPE.
Survival In Kidney Transplantation In Patients Who Used Cyclosporine Or Tacrolimus [925]
2016. 32nd ICPE.
Clinical Effectiveness and Safety of Analogue Glargine in Type 1 Diabetes: Systematic Review and Meta-Analysis [929]
2016. 32nd ICPE.
Effectiveness of Adalimumab and Etanercept for the Treatment of Rheumatoid Arthritis in the Public Health System (SUS) Belo Horizonte, Minas Gerais, Brazil [955]
2016. 32nd ICPE.
Quality of Life of Patients with Diabetes Mellitus Types 1 and 2 from a Reference Health Care Center in Minas Gerais, Brazil [1068]
2016. 32nd ICPE.
Costs with Medicines and Services in the Treatment by Patients with Schizophrenia [1072]
2016. 32nd ICPE.

Veja todas as publicações no Currículo Lattes

Orientações em andamento

Mestrado

Doutorado

Veja todas as orientações no Currículo Lattes